Sin sorpresas en la publicación de IMPROVE-IT en NEJM http://t.co/w4QJtFTw5q
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes — NEJM https://t.co/qBlp0fQH6E
Sin sorpresas en la publicación de IMPROVE-IT en NEJM http://t.co/w4QJtFTw5q
Estudio beneficios CV de añadir ezetimiba a tto estatina: tan sospechoso como metodológicamente deficiente http://t.co/6j0YnWchXp
Estudio beneficios CV de añadir ezetimiba a tto estatina: tan sospechoso como metodológicamente deficiente http://t.co/6j0YnWchXp
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes — NEJM http://t.co/4NKIcebI9G @ACRRM @RuralDoctorsAus @RuralWonca @RDA_Tas
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
[MEDICINE] Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes #MedEd #Science #mLearning ☞ http://t.co/vDCXaezaPt
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
#IMPROVE-IT via @NEJM showing improved #LDL and #CVD outcomes http://t.co/OnBKMpSVc1 http://t.co/T1EDCFWPEF
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/64WrGgk6Ec
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even more? Quick Take: http://t.co/8PLOdUgrHd
http://t.co/aj6xSaH4e3 Un video de @NEJM explicando IMPROVE-IT http://t.co/Z0Q3rmrSkH
Se ha hecho esperar....pero ya está ! Improveit: Ezetimiba añadido a estatinas tras SCA http://t.co/G3bzHqJpZZ …@Mimocardio @secardiologia
When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even more? Quick Take: http://t.co/8PLOdUgrHd
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes — NEJM http://t.co/dksTuNS0LE
When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even more? Quick Take: http://t.co/8PLOdUgrHd
@CardioNews would still want atorvastatin or rosuvastatin for secondary #CAD risk reduction http://t.co/LFBdLZIIue
Statin plus Ezetimibe reduce 2% cardiovascular mortality, 7 years follow up it lowers LDL BY 53% compare to... http://t.co/IvXWR4ov61
Ezetimibe Added to #statins Therapy after Acute #Coronary Syndromes http://t.co/tlKYdwOLoc
http://t.co/O8cejdOegY no mortality benefit MI and stroke benefit #COI #statins
http://t.co/O8cejdOegY no mortality benefit MI and stroke benefit #COI #statins
http://t.co/O8cejdOegY no mortality benefit MI and stroke benefit #COI #statins
http://t.co/O8cejdOegY no mortality benefit MI and stroke benefit #COI #statins
When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even more? Quick Take: http://t.co/8PLOdUgrHd
$MRK IMPROVE-IT Data finally published in NEJM 6mo after AHA http://t.co/okxyCGZs86 Editorial http://t.co/19Psz1DlEr http://t.co/a1WvKhBvfQ
When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even more? Quick Take: http://t.co/8PLOdUgrHd
When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even more? Quick Take: http://t.co/8PLOdUgrHd
When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even more? Quick Take: http://t.co/8PLOdUgrHd
When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even more? Quick Take: http://t.co/8PLOdUgrHd
When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even more? Quick Take: http://t.co/8PLOdUgrHd
When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even more? Quick Take: http://t.co/8PLOdUgrHd
When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even more? Quick Take: http://t.co/8PLOdUgrHd
When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even more? Quick Take: http://t.co/8PLOdUgrHd
When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even more? Quick Take: http://t.co/8PLOdUgrHd
When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even more? Quick Take: http://t.co/8PLOdUgrHd
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even more? Quick Take: http://t.co/8PLOdUgrHd
When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even more? Quick Take: http://t.co/8PLOdUgrHd
When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even more? Quick Take: http://t.co/8PLOdUgrHd
(NEJM) Publicados resultados del estudio IMPROVE-IT simvas/ezetimiba vs simvas despues de SCA http://t.co/MT08y9cW2G … vía @FarmaciaOesteAP
When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even more? Quick Take: http://t.co/8PLOdUgrHd
When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even more? Quick Take: http://t.co/8PLOdUgrHd
When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even more? Quick Take: http://t.co/8PLOdUgrHd
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes — NEJM http://t.co/zo161E2jto
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes — NEJM http://t.co/bvCbhEgD1e
http://t.co/aj6xSaH4e3 Un video de @NEJM explicando IMPROVE-IT http://t.co/Z0Q3rmrSkH
IMPROVE-IT finally published http://t.co/lwwIKB10t0
When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even more? Quick Take: http://t.co/8PLOdUgrHd
(NEJM) Publicados los resultados del estudio IMPROVE-IT simvas/ezetimiba vs simvas despues de SCA http://t.co/JrhXc0ubIv
When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even more? Quick Take: http://t.co/8PLOdUgrHd
http://t.co/aj6xSaH4e3 Un video de @NEJM explicando IMPROVE-IT http://t.co/Z0Q3rmrSkH
When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even more? Quick Take: http://t.co/8PLOdUgrHd
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
Resultados Improve-It finalmente publicados. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes — NEJM http://t.co/unaTBxMaLZ
When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even more? Quick Take: http://t.co/8PLOdUgrHd
Resultados Improve-It finalmente publicados. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes — NEJM http://t.co/unaTBxMaLZ
When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even more? Quick Take: http://t.co/8PLOdUgrHd